|
⚲
|
| Keyboard |
| AM Pappas & Associates LLC
✚
|
|
|---|---|
| CIK # | 0001320654 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001320654] | |
| 4 | [0001320654] | |
| SC 13D | [0001320654] | |
| SC 13G | [0001320654] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Pappas Capital LLC | Colucid Pharmaceuticals Inc | [2016-02-16] |
| AM Pappas & Associates LLC | Athersys Inc / New | [2012-11-05] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Liquidia Technologies Inc LQDA
Common Stock, par value $0.001 per share
|
2018-07-30 | Conversion | 97,287 | ||
|
Liquidia Technologies Inc LQDA
Series C Preferred Stock, par value $0.001 per share · derivative
|
2018-07-30 | Conversion | 1,481,553 | $0.00 | |
|
Liquidia Technologies Inc LQDA
Common Stock, par value $0.001 per share
|
2018-07-30 | Conversion | 191,788 | ||
|
Liquidia Technologies Inc LQDA
Series D Preferred Stock, par value $0.001 per share · derivative
|
2018-07-30 | Conversion | 1,637,091 | $0.00 | |
|
Kezar Life Sciences Inc KZR
Series B Preferred Stock, par value $0.001 per share · derivative
|
2018-06-25 | Conversion | 290,924 | $0.00 | |
|
Kezar Life Sciences Inc KZR
Series B Preferred Stock, par value $0.001 per share · derivative
|
2018-06-25 | Conversion | 23,894 | $0.00 | |
|
Kezar Life Sciences Inc KZR
Common Stock, par value $0.001 per share
|
2018-06-25 | Conversion | 23,894 | ||
|
Kezar Life Sciences Inc KZR
Common Stock, par value $0.001 per share
|
2018-06-25 | Conversion | 290,924 | ||
|
CoLucid Pharmaceuticals Inc CLCD
Common Stock
|
2017-03-01 | Tender | 1,871,049 | $46.50 | 87,003,778 |
|
CoLucid Pharmaceuticals Inc CLCD
Stock Option (Right to Buy) · derivative
|
2017-03-01 | Disposed to issuer | 5,954 | $36.50 | 217,321 |
|
CoLucid Pharmaceuticals Inc CLCD
Common Stock
|
2017-03-01 | Tender | 116,317 | $46.50 | 5,408,740 |
|
CoLucid Pharmaceuticals Inc CLCD
Common Stock
|
2017-03-01 | Tender | 5,528 | $46.50 | 257,052 |
|
CoLucid Pharmaceuticals Inc CLCD
Stock Option (Right to Buy) · derivative
|
2017-03-01 | Disposed to issuer | 8,897 | $40.26 | 358,193 |
|
CoLucid Pharmaceuticals Inc CLCD
Series C Convertible Preferred Stock · derivative
|
2015-05-11 | Conversion | 20,808 | $0.00 | |
|
CoLucid Pharmaceuticals Inc CLCD
Common Stock
|
2015-05-11 | Buy | 282,440 | $10.00 | 2,824,400 |
|
CoLucid Pharmaceuticals Inc CLCD
Common Stock
|
2015-05-11 | Conversion | 98,757 | ||
|
CoLucid Pharmaceuticals Inc CLCD
Common Stock
|
2015-05-11 | Buy | 17,560 | $10.00 | 175,600 |
|
CoLucid Pharmaceuticals Inc CLCD
Common Stock
|
2015-05-11 | Conversion | 1,588,607 | ||
|
CoLucid Pharmaceuticals Inc CLCD
Series B Convertible Preferred Stock · derivative
|
2015-05-11 | Conversion | 41,996 | $0.00 | |
|
CoLucid Pharmaceuticals Inc CLCD
Series B Convertible Preferred Stock · derivative
|
2015-05-11 | Conversion | 675,588 | $0.00 | |
| showing 20 of 32 most recent transactions | |||||